Downloads: 4 | Views: 183 | Weekly Hits: ⮙2 | Monthly Hits: ⮙3
Analysis Study Research Paper | Medicine | Iraq | Volume 13 Issue 11, November 2024 | Popularity: 5.3 / 10
Experience with Intravenous Biological Therapies among Iraqi Patients with Rheumatological Diseases
Ziad S. Al-Rawi, Nada Ali Aljawad, Marwa Majed Al-Sabri, Ibtihal Hikmet Hameed
Abstract: Background: Subcutaneous and intravenous administration of biologic agents differ not only in routes of administration but also in dosing schedules, costs, onset of efficacy, and immunogenicity, which are associated with patients? preferences and corresponding persistence in treatment utilization. Additionally, injection issues (depending on the route of administration and agent type) have been shown to influence patients? utilization of biological therapies. Objective: The main objective of this study was to describe patients' experiences with intravenous (IV) biologics for specific rheumatologic conditions, including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Patients and Methods: A cross - sectional study was conducted through interviews with 196 patients with the above - mentioned autoimmune rheumatic diseases who were currently receiving IV biologics at Baghdad Teaching Hospital. Patients were asked to describe the advantages and disadvantages associated with their experience of IV infusion with biologic drugs. Results: On a 7 - point Likert scale (1 = not at all satisfied; 7 = very satisfied), 90.3% of patients rated their satisfaction as 5, 6, or 7. The most frequently perceived benefit of IV therapy was related to infusion center visits, which act as an additional assessment opportunity alongside regular doctor visits; this benefit was reported by 88.8% of patients. Fifty - one percent of patients reported experiencing ?No disadvantage? in receiving IV biologic therapy, and 25% noted that the duration of infusion was too long as a perceived disadvantage. The two most common reasons for preferring IV therapy were the less frequent dosing regimen, reported by 81.6% of patients, and the belief held by 54.1% of patients that intravenous infusion was always effective; these patients had no experience with subcutaneous therapy. Conclusions: Patients using IV biologics are highly satisfied with their medications, with preferences driven by less frequent dosing, the perceived effectiveness of IV injections, and the ease of remembering dosing when an appointment is scheduled for them.
Keywords: Rheumatological patients experience, Biologics, intravenous, subcutaneous, Anti - TNF, Preferences
Edition: Volume 13 Issue 11, November 2024
Pages: 1170 - 1178
DOI: https://www.doi.org/10.21275/SR241115203222
Make Sure to Disable the Pop-Up Blocker of Web Browser
Similar Articles
Downloads: 0
Case Studies, Medicine, India, Volume 12 Issue 1, January 2023
Pages: 426 - 427A Rare Case of Disseminated Cysticercosis
Tom Geo James, Tony Mathew Austin, Purna Chandra Karua
Downloads: 0
Review Papers, Medicine, India, Volume 12 Issue 5, May 2023
Pages: 1825 - 1828A Systemic Review on Peritoneal Dialysis Catheter Type and the Resulting Complications
Soumya Pamnani
Downloads: 1 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Case Studies, Medicine, Tanzania, Volume 11 Issue 8, August 2022
Pages: 442 - 444Subcutaneous Fat Necrosis in a Newborn
Mtagi Kibatala, Asmaa Thena, Mikaly Msangi, Nancy Mugabisho, Gilbert Kwesi
Downloads: 2 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Case Studies, Medicine, Morocco, Volume 11 Issue 3, March 2022
Pages: 337 - 339Parietal Thoracic Tuberculosis in the Immunocompetent
Fahmi Asmaa, Arfaoui Hajar, Jabri Hasna, Elkhattabi Wiam, Afif Hicham
Downloads: 3 | Weekly Hits: ⮙3 | Monthly Hits: ⮙3
Case Studies, Medicine, India, Volume 14 Issue 2, February 2025
Pages: 288 - 291A Rare Presentation of Subcutaneous Emphysema Secondary to Blunt Trauma Chest
Dr. Simran Shakya, Dr. Sayantan Mukherjee, Dr. Shashwat Jindal, Dr. Sheenam Gupta